Fig. 11From: Biomaterials and advanced technologies for the evaluation and treatment of ovarian agingThe schematic diagram of the design and preparation of beta-cyclodextrin modified mesoporous bioactive glass nanoparticles/silk fibroin hybrid nanofibers. (the figure is reproduced from Wang et al. [291]with required copyright permission)Back to article page